Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |